BeiGene
ONC
#682
Rank
โ‚ฌ25.60 B
Marketcap
225,68ย โ‚ฌ
Share price
2.82%
Change (1 day)
67.55%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeiGene (ONC)

EPS in 2024 (TTM): -5,80ย โ‚ฌ

According to BeiGene 's latest financial reports the company's current EPS (TTM) is -5,50ย โ‚ฌ. .

EPS history for BeiGene from 2015 to 2024

Annual EPS

Year EPS Change
2024-5,50ย โ‚ฌ
2022-17,18ย โ‚ฌ28.21%
2021-13,40ย โ‚ฌ-19.96%
2020-16,74ย โ‚ฌ20.81%
2019-13,86ย โ‚ฌ31.52%
2018-10,54ย โ‚ฌ417.57%
2017-2,04ย โ‚ฌ-37.16%
2016-3,24ย โ‚ฌ158.95%
2015-1,25ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-0,88ย โ‚ฌ-83.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-0,24ย โ‚ฌ-95.67%๐Ÿ‡บ๐Ÿ‡ธ USA